TITLE

Identification of a new microRNA expression profile as a potential cancer screening tool

AUTHOR(S)
Roa, Wilson; Brunet, Bryan; Linghong Guo; Amanie, John; Fairchild, Alysa; Gabos, Zsolt; Nijjar, Tirath; Scrimger, Rufus; Yee, Don; James Xing
PUB. DATE
April 2010
SOURCE
Clinical & Investigative Medicine;Apr2010, Vol. 33 Issue 2, pE124
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: Small non-coding microRNAs (miRNAs) are key components of cancer development and are considered as potential biomarkers for cancer diagnosis and treatment monitoring. This study investigated miRNA expression profiles of human cancer cells in order to develop a screening method for lung cancer. Methods: A series of lung cancer related miRNAs (miR- 21, miR-145, miR-155, miR-205, miR-210, miR-92, miR- 17-5p, miR-143, miR-182, miR-372, let-7a) were selected as candidates for miRNA expression profiles of human lung cancer cell lines (A549, SK-mes-1). MicroRNA u6 was the endogenous control. Cancer cell lines for positive controls; breast MCF-7, prostate Du-145, and glioblastoma U118. The negative control was normal lung fibroblast cell line MRC-5. RT-PCR was performed on StepOnePlus (Applied Biosystem, USA). MiRNA expressions of malignant cells were compared with normal fibroblast cells as well as endogenous control (u6) using the thermal cycle at threshold. Assessment of miRNA expression profiles were then performed using agglomerative hierarchical cluster analysis software (SPSS13, USA). Results: We demonstrated that miR-21, miR-182 and let7- 5a were over-expressed, and miR-145 and miR-155 were under-expressed in all cancer cell lines. Combined with the cluster analysis we were able to clearly distinguish cell lines for normal fibroblasts, breast cancer, prostate cancer, glioblastoma, and lung cancer. Conclusion: There is potential utility of screening for lung cancer with miRNA expression profiles. Future work will focus on the sensitivity of such miRNA expression profiles in screening sputum for lung cancer, which can be performed in real time.
ACCESSION #
57155466

 

Related Articles

  • A network-based biomarker approach for molecular investigation and diagnosis of lung cancer. Yu-Chao Wang; Bor-Sen Chen // BMC Medical Genomics;2011, Vol. 4 Issue 1, p1 

    Background: Lung cancer is the leading cause of cancer deaths worldwide. Many studies have investigated the carcinogenic process and identified the biomarkers for signature classification. However, based on the research dedicated to this field, there is no highly sensitive network-based method...

  • Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models. Zhang, H; Hylander, B L; LeVea, C; Repasky, E A; Straubinger, R M; Adjei, A A; Ma, W W // British Journal of Cancer;1/21/2014, Vol. 110 Issue 2, p320 

    Background:Fibroblast growth factor receptor (FGFR) signalling has been implicated in pancreas carcinogenesis. We investigated the effect of FGFR inhibition in pancreatic cancer in complementary cancer models derived from cell lines and patient-derived primary tumour explants.Methods:The effects...

  • In this Issue.  // Kidney International;Nov2010, Vol. 78 Issue 10, p943 

    The article discusses various reports published within the issue, including one on reversal of intercalated-cell adaptation to acidosis, one on fibroblast growth factors, and one on urinary granzyme as a biomarker.

  • MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis. Mallick, Reema; Patnaik, Santosh Kumar; Yendamuri, Sai // Journal of Carcinogenesis;2010, Vol. 9 Issue 1, p1 

    MicroRNAs are tiny non-coding RNA molecules which play important roles in the epigenetic control of cellular processes by preventing the translation of proteins from messenger RNAs (mRNAs). A single microRNA can target different mRNAs, and an mRNA can be targeted by multiple microRNAs. Such...

  • Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. Weber, Daniel Gilbert; Johnen, Georg; Casjens, Swaantje; Bryk, Oleksandr; Pesch, Beate; Jöckel, Karl-Heinz; Kollmeier, Jens; Brüning, Thomas // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background The long noncoding RNA MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) is described as a potential biomarker for NSCLC (non-small cell lung cancer). Diagnostic biomarkers need to be detectable in easily accessible body fluids, should be characterized by high...

  • Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Qing Geng; Tao Fan; Boyou Zhang; Wei Wang; Yao Xu; Hao Hu // Respiratory Research;2014, Vol. 15 Issue 11, p1 

    Background: In order to find novel noninvasive biomarkers with high accuracy for the screening of early-stage non-small cell lung cancer (NSCLC), we investigate the predictive power of 5 microRNAs (miR-20a, miR-145, miR-21, miR223 and miR-221) as potential biomarkers in early-stage NSCLC....

  • Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer. Hassanein, Mohamed; Hight, Matthew; Buck, Jason; Tantawy, Mohammed; Nickels, Michael; Hoeksema, Megan; Harris, Bradford; Boyd, Kelli; Massion, Pierre; Manning, H.; Hight, Matthew R; Buck, Jason R; Tantawy, Mohammed N; Nickels, Michael L; Hoeksema, Megan D; Harris, Bradford K; Massion, Pierre P; Manning, H Charles // Molecular Imaging & Biology;Feb2016, Vol. 18 Issue 1, p18 

    Purpose: Alanine-serine-cysteine transporter 2 (ASCT2) expression has been demonstrated as a promising lung cancer biomarker. (2S,4R)-4-[(18)F]Fluoroglutamine (4-[(18)F]fluoro-Gln) positron emission tomography (PET) was evaluated in preclinical models of non-small cell lung cancer...

  • Gene Expression Tests Using Bronchial, Nasal Epithelium Under Development for Early Detection of Lung Cancer. Spira, Avrum // Personalized Medicine in Oncology;Nov2013, Vol. 2 Issue 7, p375 

    Information on the link between nasal and bronchial gene expression changes which may make nasal changes detect early lung cancer discussed at the 2013 Global Biomarkers Consortium conference is presented. The challenge is how to identify the 10% to 50% of smokers who will develop the disease in...

  • 高表达FGFR4细胞株的建立及其生物活性分析. 黄 静; 安红丽; 张 涛 // Journal of Xi'an Jiaotong University (Medical Sciences);Mar2014, Vol. 35 Issue 2, p271 

    Objective To construct the fibroblast growth factor receptor 4 (FGFR4) over-expression cell line and investigate the effects of FGFR4 on cell proliferation and mechanism of GFR4-related protein activation so as to provide a molecular model for studying anti-tumor drug candidate targeting on...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics